Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III trial of ranibizumab biosimilar FYB-201 meets primary endpoint

May 4, 2018

Sanofi reviews key events of first quarter 2018

May 4, 2018

Jiangsu Hengrui Medicine and collaborator disclose TGFR-1 inhibitors

May 4, 2018

AbbVie divulges novel BRD4 inhibitors

May 4, 2018

Ferring Pharmaceuticals acquires option to commercialize nadofaragene firadenovec/Syn3

May 4, 2018

Bristol-Myers Squibb presents new apelin receptor agonists

May 4, 2018

Ocular Therapeutix doses first patient in phase I clinical trial of OTX-TIC

May 4, 2018

FDA grants two fast track designations for 5F9

May 4, 2018

RBH-61, a dual SEH/PDE inhibitor for inflammatory pain

May 4, 2018

Phase I results reported for analgesic CCR2 antagonist CNTX-6970

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...